PIRS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pieris Pharmaceuticals, Inc. Is Fair to ShareholdersBusiness Wire • 09/03/24
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Pieris Pharmaceuticals, Inc. - PIRSPRNewsWire • 08/16/24
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates K and PIRS on Behalf of ShareholdersGlobeNewsWire • 08/16/24
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Pieris Pharmaceuticals, Inc. – PIRSGlobeNewsWire • 08/13/24
PIERIS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pieris Pharmaceuticals, Inc. - PIRSBusiness Wire • 07/24/24
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Pieris Pharmaceuticals, Inc.PRNewsWire • 07/24/24
Shareholder Alert: Ademi LLP investigates whether Pieris Pharmaceuticals, Inc. has obtained a Fair Price for its Public ShareholdersPRNewsWire • 07/24/24
Dr. Vince Clinical Research Presents Groundbreaking Webinar on Accelerating Clinical & Drug Development Timelines with AIBusiness Wire • 07/24/24
Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger AgreementAccesswire • 07/24/24
Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty PotentialAccesswire • 03/27/24
Pieris Pharmaceuticals (PIRS) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 08/23/23
Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals' Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology BispecificAccesswire • 08/17/23
Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology StudyAccesswire • 06/21/23